Browsing by Author "Grosso, Clara"
Now showing 1 - 10 of 24
Results Per Page
Sort Options
- Biological potential, gastrointestinal digestion, absorption, and bioavailability of algae-derived compounds with neuroprotective activity: a comprehensive reviewPublication . Martins, Bruna; Vieira, Mónica; Delerue-Matos, Cristina; Grosso, Clara; Soares, CristinaCurrently, there is no known cure for neurodegenerative disease. However, the available therapies aim to manage some of the symptoms of the disease. Human neurodegenerative diseases are a heterogeneous group of illnesses characterized by progressive loss of neuronal cells and nervous system dysfunction related to several mechanisms such as protein aggregation, neuroinflammation, oxidative stress, and neurotransmission dysfunction. Neuroprotective compounds are essential in the prevention and management of neurodegenerative diseases. This review will focus on the neurodegeneration mechanisms and the compounds (proteins, polyunsaturated fatty acids (PUFAs), polysaccharides, carotenoids, phycobiliproteins, phenolic compounds, among others) present in seaweeds that have shown in vivo and in vitro neuroprotective activity. Additionally, it will cover the recent findings on the neuroprotective effects of bioactive compounds from macroalgae, with a focus on their biological potential and possible mechanism of action, including microbiota modulation. Furthermore, gastrointestinal digestion, absorption, and bioavailability will be discussed. Moreover, the clinical trials using seaweed-based drugs or extracts to treat neurodegenerative disorders will be presented, showing the real potential and limitations that a specific metabolite or extract may have as a new therapeutic agent considering the recent approval of a seaweed-based drug to treat Alzheimer’s disease.
- Biological Potential, Gastrointestinal Digestion, Absorption, and Bioavailability of Algae-Derived Compounds with Neuroprotective Activity: A Comprehensive ReviewPublication . Martins, Bruna; Vieira, Mónica; Delerue-Matos, Cristina; Grosso, Clara; Soares, CristinaCurrently, there is no known cure for neurodegenerative disease. However, the available therapies aim to manage some of the symptoms of the disease. Human neurodegenerative diseases are a heterogeneous group of illnesses characterized by progressive loss of neuronal cells and nervous system dysfunction related to several mechanisms such as protein aggregation, neuroinflammation, oxidative stress, and neurotransmission dysfunction. Neuroprotective compounds are essential in the prevention and management of neurodegenerative diseases. This review will focus on the neurodegeneration mechanisms and the compounds (proteins, polyunsaturated fatty acids (PUFAs), polysaccharides, carotenoids, phycobiliproteins, phenolic compounds, among others) present in seaweeds that have shown in vivo and in vitro neuroprotective activity. Additionally, it will cover the recent findings on the neuroprotective effects of bioactive compounds from macroalgae, with a focus on their biological potential and possible mechanism of action, including microbiota modulation. Furthermore, gastrointestinal digestion, absorption, and bioavailability will be discussed. Moreover, the clinical trials using seaweed-based drugs or extracts to treat neurodegenerative disorders will be presented, showing the real potential and limitations that a specific metabolite or extract may have as a new therapeutic agent considering the recent approval of a seaweed-based drug to treat Alzheimer’s disease
- Comprehensive review on the interaction between natural compounds and brain receptors: Benefits and toxicityPublication . Silva, Ana R.; Grosso, Clara; Delerue-Matos, Cristina; Rocha, João M.Given their therapeutic activity, natural products have been used in traditional medicines throughout the centuries. The growing interest of the scientific community in phytopharmaceuticals, and more recently in marine products, has resulted in a significant number of research efforts towards understanding their effect in the treatment of neurodegenerative diseases, such as Alzheimer's (AD), Parkinson (PD) and Huntington (HD). Several studies have shown that many of the primary and secondary metabolites of plants, marine organisms and others, have high affinities for various brain receptors and may play a crucial role in the treatment of diseases affecting the central nervous system (CNS) in mammalians. Actually, such compounds may act on the brain receptors either by agonism, antagonism, allosteric modulation or other type of activity aimed at enhancing a certain effect. The current manuscript comprehensively reviews the state of the art on the interactions between natural compounds and brain receptors. This information is of foremost importance when it is intended to investigate and develop cutting-edge drugs, more effective and with alternative mechanisms of action to the conventional drugs presently used for the treatment of neurodegenerative diseases. Thus, we reviewed the effect of 173 natural products on neurotransmitter receptors, diabetes related receptors, neurotrophic factor related receptors, immune system related receptors, oxidative stress related receptors, transcription factors regulating gene expression related receptors and blood-brain barrier receptors.
- A Critical Comparison of the Advanced Extraction Techniques Applied to Obtain Health-Promoting Compounds from SeaweedsPublication . Quitério, Eva; Grosso, Clara; Ferraz, Ricardo; Delerue-Matos, Cristina; Soares, CristinaMarine macroalgae are rich in bioactive compounds that can be applied in several fields, mainly food, cosmetics, and medicine. The health-promoting effects of bioactive compounds, such as polyphenols, polysaccharides, carotenoids, proteins, and fatty acids, have been increasingly explored, especially regarding their antioxidant activity and improvement in human health. To extract these valuable compounds, advanced technologies that include Supercritical-Fluid Extraction (SFE), Pressurised-Liquid Extraction (PLE), Ultrasound-Assisted Extraction (UAE), Microwave-Assisted Extraction (MAE), Enzyme-Assisted Extraction (EAE), Ultrasound-Microwave-Assisted Extraction (UMAE) and Liquefied Gas Extraction (LGE) have been assessed due to their notable advantages over the conventional methods (Solid–Liquid and Soxhlet extraction). These advanced techniques are considerably influenced by different extraction parameters such as temperature, pressure, type of solvent, extraction time, solvent:solid material ratio, power (MAE, UAE, and UMAE), enzymes used (EAE), and factors related to the macroalgae matrix itself. Optimizing these process parameters for each method is critical to obtain better efficiency results for the targeted bioactive compounds. Macroalgae are natural sources with undeniable beneficial effects on human health. In this context, optimising the extraction techniques discussed in this review should prioritise exploiting these valuable resources’ wide range of bioactive properties
- CYTED Network: GEnoPsySEn - Development of genosensors for pharmacogenomic targets in the central nervous systemPublication . Santos, Marlene; Caldevilla, Renato; Grosso, Clara; Simal-Gandara, J.; Molina, Patricia G.; Pinto, Giovanny R.; Villa, Cristian C.; Serra, Gloria; Feria-Romero, Iris A.; Solano, Ovidio; Sanabria, Diana P. Dresseler; Souto, Pilar Villaverde; Comba, Fausto N.; Barroso, M. FátimaThe GenoPsySEN thematic network is a newly CYTED approved collaborative project between institutions and investigators from Argentina, Brazil, Colombia, El Salvador, Mexico, Spain, Paraguay, Portugal, and Uruguay, aimed at incorporating their expertise in various scientific disciplines into the successful development of genosensors for the detection of genetic variations affecting drug response in neuropsychiatric diseases. This project seeks to transfer scientific and technological results that can be applied to improve the Ibero-American Public Health Systems and contribute to reducing the number of patients without adequate treatment.
- Evaluation of the Biological Potential of Himanthalia elongata (L.) S.F.Gray and Eisenia bicyclis (Kjellman) Setchell Subcritical Water ExtractsPublication . Gomes, Inês; Rodrigues, Helena; Rodrigues, Carla; Oliveira, Marta Marques; Paíga, Paula; Paiva, Alexandre; Simões, Pedro; Fernandes, Virgínia Cruz; Vieira, Mónica; Delerue-Matos, Cristina; Soares, Cristina; Grosso, ClaraNeuroprotection is a need that remains unmet in treating chronic neurodegenerative disorders, despite decades of extensive research. To find new neuroprotective compounds, extracts of Himanthalia elongata (L.) S.F.Gray and of Eisenia bicyclis (Kjellman) Setchell were obtained through subcritical water extraction applying a four-step temperature gradient. The fractions obtained were screened against brain enzymes involved in neurodegenerative etiology, namely in Alzheimer’s and Parkinson’s diseases, and against reactive oxygen and nitrogen species, all contributing factors to the progression of neurodegeneration. Results showed no significant enzyme inhibition but strong radical scavenging activities, particularly in the fourth fraction, extracted at the highest temperature (250 °C), highlighting their ability to retard oxidative and nitrosative stresses. At higher temperatures, fractions were composed of phenolic compounds and Maillard reaction products, a combination that contributed to their antioxidant activity and, consequently, their neuroprotective properties. All fractions were evaluated for the presence of iodine, 14 organochlorine and 7 organophosphorus pesticides, and pharmaceuticals used in Alzheimer’s and Parkinson’s diseases (14), psychiatric drugs (8), and metabolites (8). The fractions studied did not present any of the screened contaminants, and only fraction 1 of E. bicyclis should be used with caution due to iodine content.
- Evaluation of the biological potential of Himanthalia elongata (L.) S.F.Gray and Eisenia bicyclis (Kjellman) setchell subcritical water extractsPublication . Gomes, Inês; Rodrigues, Helena; Rodrigues, Carla; Marques, Marta; Paíga, Paula; Paiva, Alexandre; Simões, Pedro; Cruz Fernandes, Virgínia; Vieira, Mónica; Delerue-Matos, Cristina; Soares, Cristina; Grosso, ClaraNeuroprotection is a need that remains unmet in treating chronic neurodegenerative disorders, despite decades of extensive research. To find new neuroprotective compounds, extracts of Himanthalia elongata (L.) S.F.Gray and of Eisenia bicyclis (Kjellman) Setchell were obtained through subcritical water extraction applying a four-step temperature gradient. The fractions obtained were screened against brain enzymes involved in neurodegenerative etiology, namely in Alzheimer’s and Parkinson’s diseases, and against reactive oxygen and nitrogen species, all contributing factors to the progression of neurodegeneration. Results showed no significant enzyme inhibition but strong radical scavenging activities, particularly in the fourth fraction, extracted at the highest temperature (250 °C), highlighting their ability to retard oxidative and nitrosative stresses. At higher temperatures, fractions were composed of phenolic compounds and Maillard reaction products, a combination that contributed to their antioxidant activity and, consequently, their neuroprotective properties. All fractions were evaluated for the presence of iodine, 14 organochlorine and 7 organophosphorus pesticides, and pharmaceuticals used in Alzheimer’s and Parkinson’s diseases (14), psychiatric drugs (8), and metabolites (8). The fractions studied did not present any of the screened contaminants, and only fraction 1 of E. bicyclis should be used with caution due to iodine content.
- Exploring the antiradical potential of species from Lamiaceae family: implications for functional food development in the context of neurodegenerative and neuropsychiatric diseasesPublication . Campinho, Ana; Alves, Joana; Martins, Rosário; Vieira, Mónica; Grosso, Clara; Delerue-Matos, CristinaNeurodegenerative and neuropsychiatric diseases have become highly significant in Western societies. Unfortunately, these diseases currently lack a cure, and existing treatments merely manage the symptoms. Thus, it is imperative to explore new alternatives for either preventing these disorders or treating them effectively. One promising avenue for prevention lies in the development of neuroprotective and antioxidant functional foods. To this end, a study focused on ten species from the Lamiaceae family, which have attracted attention due to their well-known antioxidant, anti-inflammatory, anti-obesity, and anti-cancer properties, among others. The interest in their pharmacological applications has grown significantly in recent years. In order to uncover the biological potential of these species, the study involved performing decoctions and evaluating both the total phenolic content (TPC) and antiradical activity. The results revealed that TPC values ranged from 59.97 ± 6.18 (Ocimum basilicum L. var minimum) to 374.0 ± 16.9 (Salvia officinalis L.) mg gallic acid equivalents (GAE)/g of dry extract (dw). Additionally, the IC50 values for DPPH• and ABTS•+ scavenging activities varied between 21.55 ± 1.18 (Origanum vulgare L.) and 132.0 ± 15.3 μg/mL (O. basilicum var minimum), and from 14.79 ± 0.50 (O. vulgare) to 44.65 ± 2.34 μg/mL (O. basilicum), respectively. The observed strong antiradical activity holds great promise for the future development of functional foods aimed at combating the oxidative stress implicated in these diseases and promoting overall brain health. By harnessing the potential of these species from Lamiaceae family, we may pave the way for innovative approaches to tackle neurodegenerative and neuropsychiatric conditions.
- From plants to psycho-neurology: unravelling the therapeutic benefits of bioactive compounds in brain disordersPublication . Grosso, Clara; Santos, Marlene; Barroso, M. FátimaThe brain’s sensitivity to oxidative stress and neuronal cell death requires effective pharmacotherapy approaches. Current pharmacological therapies are frequently ineffective and display negative side effects. Bioactive chemicals found in plants may provide a potential alternative due to their antioxidant and neuroprotective properties and can be used in therapy and the management of a variety of neuropsychiatric, neurodevelopmental, and neurodegenerative illnesses. Several natural products, including vitamin C, Cammelia sinensis polyphenols, Hypericum perforatum, and Crocus sativus have shown promise in lowering oxidative stress and treating symptoms of major depressive disorder (MDD). Similarly, bioactive compounds such as curcumin, luteolin, resveratrol, quercetin, and plants like Acorus gramineus, Rhodiola rosea, and Ginkgo biloba are associated with neuroprotective effects and symptom improvement in neurodevelopmental disorders such as autism spectrum disorder (ASD) and attention deficit/hyperactivity disorder (ADHD). Furthermore, in neurodegenerative diseases, natural compounds from Rhodiola rosea, Morinda lucida, and Glutinous rehmannia provide neurological improvement. Further study in clinical samples is required to thoroughly investigate the therapeutic advantages of these bioactive substances for persons suffering from these illnesses.
- Functionalized liposomes and phytosomes loading Annona muricata L. aqueous extract: Potential nanoshuttles for brain-delivery of phenolic compoundsPublication . Mancini, Simona; Nardo, Luca; Gregori, Maria; Ribeiro, Inês; Mantegazza, Francesco; Delerue-Matos, Cristina; Masserini, Massimo; Grosso, ClaraMulti-target drugs have gained significant recognition for the treatment of multifactorial diseases such as depression. Under a screening study of multi-potent medicinal plants with claimed antidepressant-like activity, the phenolic-rich Annona muricata aqueous extract (AE) emerged as a moderate monoamine oxidase A (hMAO-A) inhibitor and a strong hydrogen peroxide (H2O2) scavenger.
- «
- 1 (current)
- 2
- 3
- »